Molecular Neurodegeneration Impact Factor, Quartile, Indexing, Ranking

Molecular Neurodegeneration Impact Factor, Indexing, Ranking

Molecular Neurodegeneration (MN) is a scholarly journal dedicated to publishing research in the field of Neuroscience, and Published by BioMed Central. The Print-ISSN of Molecular Neurodegeneration is 1750-1326 and its abbreviation is Mol Neurodegener.

The latest Impact Factor of the Molecular Neurodegeneration for 2024-2025 is 15.8 .

The Publicaiton fees (APC) is 2590 EUR, 2990 USD, 2090 GBP.


Molecular Neurodegeneration Aim and Scope

Molecular Neurodegeneration is an open access, peer-reviewed journal that encompasses all aspects of neurodegeneration research at the molecular and cellular levels.

Neurodegenerative diseases collectively refer to neurological disorders that result from neurodegeneration and include, but are not limited to, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and glaucoma. These diseases, which are often associated with advanced aging and display varying degrees of dementia, have become a significant public health issue as humans live longer and the aging population grows larger. Recent advances in the molecular and cellular mechanisms underlying the pathogenesis of these neurodegenerative disorders have allowed for a better understanding of the disease mechanisms.


Molecular Neurodegeneration Details


Journal title Molecular Neurodegeneration (MN)
Abbreviation Mol Neurodegener
Print ISSN 1750-1326
Publisher Name BioMed Central
Editor-in-chief Guojun Bu, USA
Subject Category Neuroscience
Access type Logo of open access journals Open Access
Status 🟢 Active

Molecular Neurodegeneration Metrics and Rankings

In the context of academic journals, "Metrics and Rankings" refer to various measures and evaluations used to assess the quality, influence, and impact of a journal.

Below are the metrics and rankings for the journal Molecular Neurodegeneration

Impact Factor 15.8
SJR 5.158
SNIP 3.022
Ranking 264
CiteScore 25.0
H-Index 103
Quartile Q1
Molecular Neurodegeneration Impact Factor List

Molecular Neurodegeneration Review Time

Journal review time is basically how long it takes for experts to read and decide whether an article is good enough to be published in a journal.

Review Time 124 days

Molecular Neurodegeneration Abstracting and Indexing

Abstracting and Indexing (A&I) refers to the processes that help organize and categorize academic journals, making them easier to find and access for researchers and scholars

Abstracting and Indexing

Molecular Neurodegeneration Submission

If you would like to submit a manuscript or visit the journal's website, please click on the link below.

Journal Submission 🔗 Journal Website

F T L W E